Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01579396

High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery

The Effects of High-cutoff (HCO) Hemofiltration in the Immediate Postoperative Period on Systemic Inflammatory Response Syndrome (SIRS) and Renal Recovery in Cardiac Surgery Patients With a High Risk for Renal Failure. (HICOSIRS)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Vantive Health LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A high cut off dialyzer (septeX) is tested in patients after cardio-thoracic surgery with incidence of "systemic inflammatory response syndrome" (SIRS) and associated increased risk for acute kidney injury (AKI). Hypothesis: The high cut off dialyzer (septeX) can increase the postoperative IL-6/Il-10 ratio.

Detailed description

Cardiac surgery associated systemic inflammatory response syndrome (SIRS) plays an important pathophysiological role in the development of AKI in patients after cardiothoracic surgery. Previous studies have shown that the elimination of inflammatory mediators can be either achieved by Continuous Venous Venous Hemodialysis(CVVHD) or Continuous Venous Venous Hemofiltration (CVVH) by using a high-cutoff (HCO) membrane with a cut-off 45kD. Data from patients treated with HCO-CVVHD during septic shock show a reduction in systemic cytokines and improved hemodynamics. No data about the effects of early HCO-CVVH in cardiac surgery patients with a high risk of Cardiac Surgery associated AKI and consequently a high rate of postoperative renal replacement therapy (RRT) are available. It is of note that patients with Euroscore \> 6 are on high risk to develop SIRS associated AKI. No pharmacological anti-inflammatory approach has convincingly shown to prevent renal dysfunction in these patients.

Conditions

Interventions

TypeNameDescription
DEVICEsepteX12 h septeX CVVH treatment after cardiac surgery
OTHERstandard therapystandard therapy either pharmacological and /or continuous renal replacement therapy (CRRT)

Timeline

Start date
2012-04-01
Primary completion
2013-09-01
Completion
2013-12-01
First posted
2012-04-18
Last updated
2025-03-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01579396. Inclusion in this directory is not an endorsement.